Trials / Completed
CompletedNCT00371956
Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy
Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy: a Randomized Double-blind Placebo-controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Tuen Mun Hospital · Other Government
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a double-blind placebo-controlled trial evaluating the efficacy of raloxifene in the prevention of bone mineral density loss in patients receiving long term corticosteroids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | raloxifene | 60mg/day |
| DRUG | placebo | tab 1 daily |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2010-02-01
- Completion
- 2010-02-01
- First posted
- 2006-09-04
- Last updated
- 2010-09-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00371956. Inclusion in this directory is not an endorsement.